PDEXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30
PRO DEX INC
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 3, 2026
$57.70−0.56 (-0.96%)
Close on Oct 19, 2026
- Market cap
- $193.98M
- P/E (TTM)
- 14.0
- Dividend yield
- –
PRO DEX INC revenue by segment
By business segment
| Revenue | TTM Q1 17 | TTM Q4 16 | TTM Q3 16 | TTM Q2 16 | TTM Q1 16 | TTM Q4 15 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|
| Pro-Dex [Member] | $18.35M | $17.16M | $16.47M | $15.29M | $12.81M | $11.62M | 85.5% | +43.3% |
| Fineline [Member] | $1.32M | $1.30M | $1.07M | $743.00K | – | $257.00K | 6.1% | – |
| OMS [Member] | $948.00K | $969.00K | $942.00K | $1.18M | $1.34M | $1.39M | 4.4% | -29.0% |
| ESD [Member] | $860.00K | $730.00K | $470.00K | $318.00K | $224.00K | $115.00K | 4.0% | +283.9% |
| Operating income | TTM Q1 17 | TTM Q4 16 | TTM Q3 16 | TTM Q2 16 | TTM Q1 16 | TTM Q4 15 | YoY |
|---|---|---|---|---|---|---|---|
| Pro-Dex [Member] | $2.28M | $1.99M | $2.34M | $1.65M | $668.00K | $75.00K | +241.6% |
| ESD [Member] | -$45.00K | -$70.00K | -$202.00K | -$346.00K | -$385.00K | -$361.00K | -88.3% |
| OMS [Member] | -$253.00K | -$282.00K | -$630.00K | -$452.00K | -$290.00K | $144.00K | -12.8% |
| Fineline [Member] | -$366.00K | -$415.00K | -$409.00K | -$112.00K | – | -$33.00K | – |
| Corporate Unallocated [Member] | -$680.00K | -$692.00K | -$699.00K | -$785.00K | -$763.00K | -$727.00K | -10.9% |
By product or service
By region
From the segment and revenue-disaggregation notes of Pro Dex's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.